Health

Results: 289-300 of 9489

PR Newswire associated0

HitGen Partner BioAge Labs Doses First Participant in Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor for Cardiovascular Risk Reduction

Hennick Humber Hospital in Canada has selected Sectra One Cloud to speed up patient diagnostics with improved radiology workflows

Business Wire logo

Insulet Partners with Calm to Bring Mindfulness and Well-Being Tools to the Diabetes Community, Featuring a New Sleep Story Narrated by Lila Moss

FDA approves Leqembi Iqlik® (lecanemab-irmb) subcutaneous injection as a starting dose for early Alzheimer's disease

BRITISH CHARITY LAUNCHES WHAT IS BELIEVED TO BE AMONG THE WORLD'S MOST COMPREHENSIVE AUTOIMMUNE AWARENESS PLATFORMS

PR Newswire associated0

Alzheimer's Survivor, 82, Takes on a 650-Mile Cross-Country Challenge from Land's End to London

Business Wire logo

Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia Telangiectasia (A-T)

PR Newswire associated0

Servier completes the acquisition of Edgewise Therapeutics' Muscular Dystrophy Business

Business Wire logo

Tenpoint Therapeutics Announces United Kingdom Submission of Marketing Authorization Application to the Medicines and Healthcare Products Regulatory Agency (MHRA) for the Treatment of Blurry Close-Up Vision (Presbyopia) in Adults

HistoSonics Edison® Histotripsy System

HistoSonics Receives CE Mark, Unlocking Access Across Europe and Accelerating Global Commercialization of the Edison® Histotripsy Platform

Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension Study Interim Analysis

GlobeNewswire associated0

Brain Training Shown to Reduce Amyloid Indicative of Alzheimer’s